Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosario Pivonello

Showing results (1-10 of 334) with videos related to

Pageof 34
Sort By:
Clinical Endocrinology|January 21, 2012
Quality of life in patients with Cushing's disease: a modern approachAnnamaria Colao, Alessia Cozzolino, Rosario Pivonello
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|December 17, 2008
Bariatric surgery for obesity and hidden Cushing syndromeSilvia Savastano, Rosario Pivonello, Annamaria Colao
Progress in Brain Research|June 15, 2010
Somatostatin analogues: treatment of pituitary and neuroendocrine tumorsAnnamaria Colao, Antongiulio Faggiano, Rosario Pivonello
Pituitary|August 21, 2015
The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegalyAnnamaria Colao, Renata S Auriemma, Rosario Pivonello
The Lancet. Diabetes & Endocrinology|November 6, 2017
Cardiovascular risk after cessation of growth hormone treatment in people born small for gestational ageRosario Pivonello, Carolina Di Somma, Annamaria Colao
The Lancet. Diabetes & Endocrinology|May 6, 2014
How should patients with adrenal incidentalomas be followed up?Rosario Pivonello, Maria Cristina De Martino, Annamaria Colao
Treatments in Endocrinology|August 28, 2004
Cardiac abnormalities in acromegaly. Pathophysiology and implications for managementGiovanni Vitale, Rosario Pivonello, Gaetano Lombardi, et al.
Endocrinology and Metabolism Clinics of North America|April 27, 2005
The metabolic syndrome and cardiovascular risk in Cushing's syndromeRosario Pivonello, Antongiulio Faggiano, Gaetano Lombardi, et al.
Current Opinion in Endocrinology, Diabetes, and Obesity|May 26, 2012
Somatostatin analogs as a first-line treatment in acromegaly: when is it appropriate?Ludovica F S Grasso, Rosario Pivonello, Annamaria Colao
Expert Opinion on Investigational Drugs|June 5, 2013
Investigational therapies for acromegalyLudovica F S Grasso, Rosario Pivonello, Annamaria Colao
Pageof 34

Showing results (1-10 of 334) with videos related to

Sort By:
Pageof 34
Clinical Endocrinology|January 21, 2012
Quality of life in patients with Cushing's disease: a modern approachAnnamaria Colao, Alessia Cozzolino, Rosario Pivonello
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|December 17, 2008
Bariatric surgery for obesity and hidden Cushing syndromeSilvia Savastano, Rosario Pivonello, Annamaria Colao
Progress in Brain Research|June 15, 2010
Somatostatin analogues: treatment of pituitary and neuroendocrine tumorsAnnamaria Colao, Antongiulio Faggiano, Rosario Pivonello
Pituitary|August 21, 2015
The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegalyAnnamaria Colao, Renata S Auriemma, Rosario Pivonello
The Lancet. Diabetes & Endocrinology|November 6, 2017
Cardiovascular risk after cessation of growth hormone treatment in people born small for gestational ageRosario Pivonello, Carolina Di Somma, Annamaria Colao
The Lancet. Diabetes & Endocrinology|May 6, 2014
How should patients with adrenal incidentalomas be followed up?Rosario Pivonello, Maria Cristina De Martino, Annamaria Colao
Treatments in Endocrinology|August 28, 2004
Cardiac abnormalities in acromegaly. Pathophysiology and implications for managementGiovanni Vitale, Rosario Pivonello, Gaetano Lombardi, et al.
Endocrinology and Metabolism Clinics of North America|April 27, 2005
The metabolic syndrome and cardiovascular risk in Cushing's syndromeRosario Pivonello, Antongiulio Faggiano, Gaetano Lombardi, et al.
Current Opinion in Endocrinology, Diabetes, and Obesity|May 26, 2012
Somatostatin analogs as a first-line treatment in acromegaly: when is it appropriate?Ludovica F S Grasso, Rosario Pivonello, Annamaria Colao
Expert Opinion on Investigational Drugs|June 5, 2013
Investigational therapies for acromegalyLudovica F S Grasso, Rosario Pivonello, Annamaria Colao
Pageof 34